Melinda A. Maggard, MD, MSHS; Lisa R. Shugarman, PhD; Marika Suttorp, MS; Margaret Maglione, MPP; Harvey J. Sugerman, MD; Edward H. Livingston, MD; Ninh T. Nguyen, MD; Zhaoping Li, MD, PhD; Walter A. Mojica, MD, MPH; Lara Hilton, BA; Shannon Rhodes, MFA; Sally C. Morton, PhD; Paul G. Shekelle, MD, PhD
Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al. Meta-Analysis: Surgical Treatment of Obesity. Ann Intern Med. 2005;142:547-559. doi: 10.7326/0003-4819-142-7-200504050-00013
Download citation file:
Published: Ann Intern Med. 2005;142(7):547-559.
Controversy exists regarding the effectiveness of surgery for weight loss and the resulting improvement in health-related outcomes.
To perform a meta-analysis of effectiveness and adverse events associated with surgical treatment of obesity.
MEDLINE, EMBASE, Cochrane Controlled Trials Register, and systematic reviews.
Randomized, controlled trials; observational studies; and case series reporting on surgical treatment of obesity.
Information about study design, procedure, population, comorbid conditions, and adverse events.
The authors assessed 147 studies. Of these, 89 contributed to the weight loss analysis, 134 contributed to the mortality analysis, and 128 contributed to the complications analysis. The authors identified 1 large, matched cohort analysis that reported greater weight loss with surgery than with medical treatment in individuals with an average body mass index (BMI) of 40 kg/m2 or greater. Surgery resulted in a weight loss of 20 to 30 kg, which was maintained for up to 10 years and was accompanied by improvements in some comorbid conditions. For BMIs of 35 to 39 kg/m2, data from case series strongly support superiority of surgery but cannot be considered conclusive. Gastric bypass procedures result in more weight loss than gastroplasty. Bariatric procedures in current use (gastric bypass, laparoscopic adjustable gastric band, vertical banded gastroplasty, and biliopancreatic diversion and switch) have been performed with an overall mortality rate of less than 1%. Adverse events occur in about 20% of cases. A laparoscopic approach results in fewer wound complications than an open approach.
Only a few controlled trials were available for analysis. Heterogeneity was seen among studies, and publication bias is possible.
Surgery is more effective than nonsurgical treatment for weight loss and control of some comorbid conditions in patients with a BMI of 40 kg/m2 or greater. More data are needed to determine the efficacy of surgery relative to nonsurgical therapy for less severely obese people. Procedures differ in efficacy and incidence of complications.
Reprinted with permission from the American Society for Bariatric Surgery (http://www.asbs.org).
Lap = laparoscopic; RYGB = Roux-en-Y gastric bypass; VBG = vertical banded gastroplasty.
Appendix Table 1.
Appendix Table 2.
Appendix Table 3.
Appendix Table 4.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Harvey J Sugerman
Virginia Commonwealth University
April 22, 2005
To the editor:
We appreciate the attention Annals has given to the management of obesity, in the form of Clinical Guidelines, a Meta-Analysis with Editors' Notes, and a Summary for Patients [Ann Int Med 2005; 142(7)], although we have several concerns regarding the contents.
The American College of Physicians (ACP) Clinical Guidelines for Pharmacologic and Surgical Management of Obesity are inappropriately confining, potentially leading to denial of effective treatment for severely obese patients. The guidelines do not provide a balanced assessment of the relative long-term efficacy of non-surgical treatments such as diets, behavior modification, exercise, drugs or combinations of these modalities, in patients with body mass index (BMI) 35 kg/m or greater with serious co-morbidities. More than 95% of severely obese patients fail such treatments after less than two years, and, on average, have made more than 5 unsuccessful attempts prior to referral for bariatric surgery.
The Summary for Patients, regarding the benefits of a mean weight loss of 11 lbs during on-going non-surgical treatment (drugs, diets, etc), is misleading, if not disingenuous. Immediately after cessation of the 6-12 months of treatment, much of which is associated with alarmingly high drop-out rates, virtually 100% of patients return to their previous poor health. This rate of failure is extremely frustrating to both the patients and Primary Care physicians.
The Guidelines list of co-morbidities of obesity requiring treatment is remarkably incomplete; asthma, gastroesophageal reflux, liver disease, obesity hypoventilation, pseudotumor cerebri, stress incontinence, polycystic ovary syndrome and venostasis disease, among others, are all serious and limit the quality and even length of life. There are numerous consistent confirmatory case-series in peer-reviewed publications demonstrating the long-term efficacy of surgical treatment. Three large studies revealed mortality reduction compared to medically treated cohorts (1-3), yet the published algorithm in your Guidelines doesn't even mention a surgical treatment option!
Your "Editors* Notes", boldy displayed in "Meta-analysis: surgical treatment of obesity" (rather than on an editorial page), directly contradicts the preponderance of evidence regarding "..effectiveness of surgical therapy in the treatment of obesity..". One meta-analysis4 and several "evidence-based" reports [stman J et al.(5), Sauerland S et al.(6), Clegg et al.(7), including the Meta-Analysis by Maggard et al. presented in this very issue of Annals], although flawed, concur with the 1991 National Institutes of Health Consensus panel (9) affirming the effectiveness and safety of surgery for obesity. Evidence based medicine criteria for assessment of strength of evidence mandating randomized controlled or cohort studies, are inappropriate for evaluating invasive treatments such as operations which have robust physiological and behavioral effects, are difficult to reverse and may have more serious and variable side-effects than the drug studies for which the criteria were developed.
Ample data reveal the effect of surgeons' case volumes on outcome in most types of operations, including anti-obesity surgery.(3,9) The American Society for Bariatric Surgery, recognizing an increasing number of adverse outcomes in step with the increasing demand for this surgery, has created a bariatric surgery accreditation program to assure physicians and patients alike that a high quality of care is being provided. Severe obesity is extremely difficult to manage in primary care. However, overly restrictive, incomplete treatment guidelines, such as those just published, are a disservice to all parties.
Harvey J. Sugerman, MD President American Society for Bariatric Surgery Emeritus Professor of Surgery Virginia Commonwealth University Richmond, Virginia email@example.com
John G. Kral, MD, PhD Professor of Surgery and Medicine SUNY Downstate Medical Center Brooklyn, New York
1.MacDonald KG, Jr., Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ. The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. J Gastrointest Surg 1997; 1:213-20. [PMID: 9834350]
2.Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long -term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416-23; discussion 423-4. [PMID: 15319713]
3.Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg 2004; 199:543-51. [PMID: 15454136]
4.Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systemic review and meta-analysis. JAMA 2004; 292:1724-37. [PMID: 15479938]
5.*stman J, Britton M, Jonson E. Treating and preventing obesity: an evidence based review. WILEY-CVH verlag GmbH & Co Kga A, Weinhem, 2004.
6.Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2004; Dec 2; [Epub ahead of print].[PMID 15580436]
7.Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003; 27:1167-77. [PMID:14513064]
8.NIH Conference: Gastrointestinal surgery for severe obesity: Consensus Development Conference Panel. Ann Intern Med 1991; 115:956-61. [PMID: 1952493]
9.Courcoulas A, Schuchert M, Gatti G, Luketich J. The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery 2003; 134:613-21. [PMID: 14605622]
President, American Society for Bariatric Surgery
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only